-Live Mint SC judgement may not open a floodgate of revenues for local pharma firms; nevertheless, it is a psychological win The Supreme Court has dismissed an appeal by Novartis AG to revoke denial of a patent to its cancer drug Glivec. The judgement is important because multinational companies (MNCs) can be denied patent protection on improved drugs unless they can prove the medication has better efficacy. Although this decision will displease...

-The Business Standard Patients' lobbies cheer ruling on anti-cancer drug Glivec, as affordability and access to life-saving drugs get a leg-up Though the India office here of Swiss pharma giant Novartis wore a gloomy look following the Supreme Court rejection of its Glivec patent application, Indian pharmaceutical companies and patients' associations are in celebration mood. D G Shah, secretary general, The Indian Pharmaceutical Alliance (IPA), comprising leading research-based Indian pharma companies, said,...

-The Economic Times Should drug companies make clinical trials data public? All over the world, drug regulators are increasingly in favour of doing so, much to the discomfort of pharmaceutical companies, and the London-based European Medicines Agency (EMA) is the first mover in this regard. As the journal Nature reports, EMA is likely to do so by next year, at least for some clinical trials data. On April 19, all the...

-The Indian Express No country has ever achieved prosperity without engaging with science and technology (S&T). The ascent of the West and its global domination owes much to its prowess in S&T. In Asia, Japan and South Korea and more recently China have taken the highway to prosperity by mastering technology and effectively dealing with complexity. Chinese economist Justin Yufi Lin in his book The Quest for Prosperity has argued that...

-The Indian Express As in the case of lawyers and doctors, a formal qualification must be prescribed for journalists Journalists comment on everything under the sun. But when someone comments on their profession, they let loose furious fusillades flaunting the slogan, "the freedom of the media in danger". Most condemn even the suggestion of a public debate on the issue of media regulation and responsibilities. No one can deny my credentials as a...